Clinical Trials
10 trialsNCT00080054 2009-04-03
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Pharmacyclics LLC.
Phase 1 Completed
NCT00102505 2009-04-03
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
Pharmacyclics LLC.
Phase 1 Completed
NCT00120939 2009-04-03
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
Pharmacyclics LLC.
Phase 1 Completed
NCT00290004 2008-09-11
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Pharmacyclics LLC.
Phase 1/2 Completed
NCT00129844 2008-08-20
Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
Pharmacyclics LLC.
Phase 2 Completed
NCT00080041 2007-05-15
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
Pharmacyclics LLC.
Phase 1 Completed
NCT00086034 2007-05-15
Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Pharmacyclics LLC.
Phase 2 Completed
NCT00054795 2007-05-08
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Pharmacyclics LLC.
Phase 3 Completed
NCT00134186 2007-03-05
Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer
Pharmacyclics LLC.
Phase 2 Completed
NCT00096837 2006-06-08
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
Pharmacyclics LLC.
Phase 2 Completed